Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Trial Profile

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Risperidone (Primary)
  • Indications Aggression; Autistic disorder; Bipolar disorders; Dementia; Drug abuse; Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 28 Mar 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 26 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top